title: The Golden Agers and Tick-borne encephalitis. Conference report and position paper of the International Scientific Working Group on Tick-borne encephalitis.
abstract: The 7th meeting of the ISW TBE had the main topic "Tick-borne encephalitis in the Golden Agers". Data from 14 European countries were presented about incidence and clinical course of Tick borne encephalitis (TBE) in general and especially in the population over 50 years of age. With age immunity is impaired quantitatively and qualitatively, the reactions to vaccinations are generally slower, antibody titres reach lower values and decrease earlier. The incidence of the disease is increasing with age, also the clinical course is more severe, they suffer significantly more sequelae, need a longer rehabilitation and have a higher case fatality. Vaccination as the only efficient protection is needed in endemic areas, considering that mobility has increased very much. For the age group over 50 years regular booster vaccinations according to the recommended vaccination intervals or even shorter intervals are most important.
authors: Institute of Social Medicine, Center of Public Health, Medical University Vienna, Vienna, Austria. ursula.kunze@meduniwien.ac.at
authors: Ursula
authors: U
authors: Kunze
authors: Ulf
authors: U
authors: Baumhackl
authors: Rudolf
authors: R
authors: Bretschneider
authors: Vaclav
authors: V
authors: Chmelik
authors: Beatrix
authors: B
authors: Grubeck-Loebenstein
authors: Mats
authors: M
authors: Haglund
authors: Franz
authors: F
authors: Heinz
authors: Reinhard
authors: R
authors: Kaiser
authors: Peter
authors: P
authors: Kimmig
authors: Christian
authors: C
authors: Kunz
authors: Michael
authors: M
authors: Kunze
authors: Aukse
authors: A
authors: Mickiene
authors: Ljiljana
authors: L
authors: Misic-Majerus
authors: Sarah
authors: S
authors: Randolph
authors: Burkhard
authors: B
authors: Rieke
authors: Pawel
authors: P
authors: Stefanoff
authors: Jochen
authors: J
authors: Süss
authors: Ronald
authors: R
authors: Wimmer
mesh_terms: D000367:Age Factors; D000368:Aged; D003430:Cross-Sectional Studies; D004669:Encephalitis Viruses, Tick-Borne / Q000276:immunology; D004675:Encephalitis, Tick-Borne / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control; D019353:Endemic Diseases; D005060:Europe; D006801:Humans; D007117:Immunization, Secondary; D015994:Incidence; D008875:Middle Aged; D009894:Opportunistic Infections / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control; D012955:Societies, Medical; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology
chemical_list: D014765:Viral Vaccines